Association Between Periostin Expression and Disease Progression in Lichen Planopilaris: Insights Into Pathophysiology
Periostin Expression in Lichen Planopilaris
Keywords:
Periostin Biomarker, Scalp Inflammation, Fibrotic Alopecia, Dermatopathology, Autoimmune Hair Disorder, Trichology ResearchAbstract
Introduction: Lichen planopilaris (LPP) is the most prevalent form of scarring alopecia and lymphocytic infiltration that affects the infundibulum and isthmus, perifollicular melanophages, and perifollicular constrictive fibrosis
Objective: We aimed to assess the contribution of periostin tissue levels to the pathogenesis of LPP and its association with disease severity.
Methods: A total of 30 cases diagnosed with LPP between July 15 and October 15, 2022 were studied. Patient age, disease duration, disease severity, and periostin levels were recorded, and periostin immunohistochemistry was performed to obtain histoscores for the perifollicular area, dermoepidermal junction, fibroblasts, and inflammatory cells, and these were compared with the control group.
Results: The female sex predominated, with the majority (67%); 25 patients were classified with mild disease and five with severe LPP. Statistically significant differences were found in keratinocyte staining intensities between the mild and severe groups (P=0.023; P<0.01), with the LPP group exhibiting a higher rate of moderate staining intensity compared to the control group. In terms of perifollicular staining intensities, the rate of non-staining was higher in the control group compared to the LPP group. Statistically significant differences were also observed in fibroblast (P=0.001) and inflammatory cell (P=0.001) staining intensities between the groups. No statistically significant difference was found between the patients with mild or severe disease in the LPP group.
Conclusion: The relationship between periostin and disease severity could not be conclusively established. The presence of periostin staining in all histopathologically-affected areas of patients with LPP suggests that periostin may serve as a promising marker in LPP.
References
Cantwell HM, Wieland CN, Proffer SL, Imhof RL, Torgerson RR, Tolkachjov SN. Lichen planopilaris in men: a retrospective clinicopathologic study of 19 patients. Int J Dermatol. 2021; 60(4): 482-8. DOI: 10.1111/ijd.15285
Lajevardi V, Mahmoudi H, Moghanlou S, Ansari M, Teimourpour A, Daneshpazhooh M. Assessing the correlation between trichoscopic features in lichen planopilaris and lichen planopilaris activity index. Australas J Dermatol. 2019; 60(3): 214-8. DOI: 10.1111/ajd.13022
Lyakhovitsky A, Amichai B, Sizopoulou C, Barzilai A. A case series of 46 patients with lichen planopilaris: Demographics, clinical evaluation, and treatment experience. J Dermatolog Treat. 2015; 26(3): 275-9. DOI: 10.3109/09546634.2014.933165
Nasimi M, Ahangari N, Lajevardi V, Mahmoudi H, Ghodsi SZ, Etesami I. Quality of life and mental health status in patients with lichen planopilaris based on Dermatology Life Quality Index and General Health Questionnaire-28 questionnaires. Int J Womens Dermatol. 2020; 6(5): 399-403. DOI: 10.1016/j.ijwd.2020.09.005
Yamaguchi Y. Periostin in skin tissue and skin-related diseases. Allergol Int. 2014; 63(2): 161-70. DOI: 10.2332/allergolint.13-RAI-0685
Elliott CG, Kim SS, Hamilton DW. Functional significance of periostin in excisional skin repair: is the devil in the detail? Cell Adh Migr. 2012; 6(4): 319-26. DOI: 10.4161/cam.20879
Kuwatsuka Y, Murota H. Involvement of Periostin in Skin Function and the Pathogenesis of Skin Diseases. Adv Exp Med Biol. 2019; 1132: 89-98. DOI: 10.1007/978-981-13-6657-4_10
Walker JT, McLeod K, Kim S, Conway SJ, Hamilton DW. Periostin as a multifunctional modulator of the wound healing response. Cell Tissue Res. 2016; 365(3): 453-65. DOI: 10.1007/s00441-016-2426-6
Fechine COC, Valente NYS, Romiti R. Lichen planopilaris and frontal fibrosing alopecia: review and update of diagnostic and therapeutic features. An Bras Dermatol. 2022; 97(3): 348-57. DOI: 10.1016/j.abd.2021.08.008
Chiang C, Sah D, Cho BK, Ochoa BE, Price VH. Hydroxychloroquine and lichen planopilaris: efficacy and introduction of Lichen Planopilaris Activity Index scoring system. J Am Acad Dermatol. 2010; 62(3): 387-92. DOI: 10.1016/j.jaad.2009.08.054
Zhang ZR, Chen LY, Qi HY, Sun SH. Expression and clinical significance of periostin in oral lichen planus. Exp Ther Med. 2018; 15(6): 5141-7. DOI: 10.3892/etm.2018.6029
Carter JH, Douglass LE, Deddens JA, et al. Pak-1 expression increases with progression of colorectal carcinomas to metastasis. Clin Cancer Res. 2004; 10(10): 3448-56. DOI: 10.1158/1078-0432.CCR-03-0210
Ranasinghe GC, Piliang MP, Bergfeld WF. Prevalence of hormonal and endocrine dysfunction in patients with lichen planopilaris (LPP): A retrospective data analysis of 168 patients. J Am Acad Dermatol. 2017; 76(2): 314-20. DOI: 10.1016/j.jaad.2016.05.038
Taniguchi K, Arima K, Masuoka M, et al. Periostin controls keratinocyte proliferation and differentiation by interacting with the paracrine IL-1alpha/IL-6 loop. J Invest Dermatol. 2014; 134(5): 1295-304. DOI: 10.1038/jid.2013.500
Agar NS, Wedgeworth E, Crichton S, et al. Survival outcomes and prognostic factors in mycosis fungoides/Sezary syndrome: validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer staging proposal. J Clin Oncol. 2010; 28(31): 4730-9. DOI: 10.1200/JCO.2009.27.7665
Furudate S, Fujimura T, Kakizaki A, et al. The possible interaction between periostin expressed by cancer stroma and tumor-associated macrophages in developing mycosis fungoides. Exp Dermatol. 2016; 25(2): 107-12. DOI: 10.1111/exd.12873
Kakizaki A, Fujimura T, Furudate S, Kambayashi Y, Aiba S. Immunohistochemical Similarities between Lichen Sclerosus et Atrophicus and Morphea: A Case Study. Case Rep Dermatol. 2015; 7(1): 39-45. DOI: 10.1159/000381010
Zhang Z, Nie F, Kang C, et al. Increased periostin expression affects the proliferation, collagen synthesis, migration and invasion of keloid fibroblasts under hypoxic conditions. Int J Mol Med. 2014; 34(1): 253-61. DOI: 10.3892/ijmm.2014.1760
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Şenay Ağırgöl, Ceyda Çaytemel, Burak Ünlü, Elif Çetinkaya, Baran Cayhan, Begüm Çalım, zafer türkoğlu
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Dermatology Practical & Conceptual applies a Creative Commons Attribution License (CCAL) to all works we publish (http://creativecommons.org/licenses/by-nc/4.0/). Authors retain the copyright for their published work.
How to Cite
Share
